Gabales, Lulito, JR.. C.
HRN: 24-89-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CEFUROXIME 1.5GM (VIAL)
06/07/2024
06/14/2024
IV
1.5 G
Q8
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes